Form 8-K - Current report:
SEC Accession No. 0001193125-25-142765
Filing Date
2025-06-18
Accepted
2025-06-18 16:41:21
Documents
12
Period of Report
2025-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d45045d8k.htm   iXBRL 8-K 46062
  Complete submission text file 0001193125-25-142765.txt   160605

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cycn-20250616.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycn-20250616_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycn-20250616_pre.xml EX-101.PRE 11266
14 EXTRACTED XBRL INSTANCE DOCUMENT d45045d8k_htm.xml XML 3628
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 251057490
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)